(Q37272860)

19 August 2017

CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study (English)

1 reference

19 August 2017

0 references

1 reference

1 reference

23

Arthur W Toga

1 reference

19 August 2017

Jon B Toledo

4

0 references

John Q. Trojanowski

25

object named as

John Q Trojanowski

1 reference

19 August 2017

5

Daniel Weintraub

1 reference

19 August 2017

18

Karl Kieburtz

1 reference

19 August 2017

20

Caroline M Tanner

1 reference

19 August 2017

2

Brit Mollenhauer

1 reference

19 August 2017

22

Andrew Singleton

1 reference

19 August 2017

21

Tanya Simuni

1 reference

19 August 2017

26

Leslie M Shaw

1 reference

19 August 2017

17

Kenneth Marek

1 reference

19 August 2017

16

Mark Frasier

1 reference

19 August 2017

19

Danna Jennings

1 reference

19 August 2017

14

Sarah Pan

1 reference

19 August 2017

11

Teresa Waligórska

1 reference

19 August 2017

9

Alice S Chen-Plotkin

1 reference

19 August 2017

Chelsea Caspell-Garcia

10

object named as

Chelsea Caspell-Garcia

1 reference

19 August 2017

Ju-Hee Kang

1

1 reference

19 August 2017

Christopher S Coffey

3

1 reference

19 August 2017

Douglas R Galasko

6

1 reference

19 August 2017

David J Irwin

7

1 reference

19 August 2017

Vivianna Van Deerlin

8

1 reference

19 August 2017

Peggy Taylor

12

1 reference

19 August 2017

Nirali Shah

13

1 reference

19 August 2017

Pawel Zero

15

1 reference

19 August 2017

Sohini Chowdhury

24

1 reference

19 August 2017

Parkinson’s Progression Marker Initiative

27

1 reference

19 August 2017

28 March 2016

1 reference

19 August 2017

Acta Neuropathologica

1 reference

19 August 2017

131

1 reference

19 August 2017

935-949

1 reference

19 August 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1007/s00401-016-1552-2

19 August 2017

0 references

cites work

Pathological α-synuclein distribution in subjects with coincident Alzheimer's and Lewy body pathology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5031365

APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5031365

Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5031365

Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5031365

Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5031365

Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5031365

Distinct α-synuclein strains differentially promote tau inclusions in neurons

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5031365

CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer's disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5031365

APOE ε4 increases risk for dementia in pure synucleinopathies

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5031365

Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5031365

Neuropathologic substrates of Parkinson disease dementia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5031365

Patterns of α-synuclein pathology in incidental cases and clinical subtypes of Parkinson's disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5031365

The Parkinson Progression Marker Initiative (PPMI).

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5031365

Neuropathology underlying clinical variability in patients with synucleinopathies

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5031365

Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5031365

Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5031365

CSF Aβ(42) and tau in Parkinson's disease with cognitive impairment.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5031365

CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5031365

Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5031365

A clinico-pathological study of subtypes in Parkinson's disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5031365

The epidemiology of dementia associated with Parkinson disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5031365

Determinants of the timing of symptomatic treatment in early Parkinson disease: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) Experience

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5031365

Alpha-Synuclein contributes to GSK-3beta-catalyzed Tau phosphorylation in Parkinson's disease models

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5031365

Evolution of cognitive dysfunction in an incident Parkinson's disease cohort.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5031365

Changes in motor subtype and risk for incident dementia in Parkinson's disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5031365

Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5031365

Post mortem studies in Parkinson's disease--is it possible to detect brain areas for specific symptoms?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5031365

α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5031365

Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5031365

CSF Aβ42 predicts early-onset dementia in Parkinson disease

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5031365

How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scale.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5031365

CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5031365

Course in Parkinson disease subtypes: A 39-year clinicopathologic study

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5031365

Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson's disease.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5031365

Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5031365

Globus pallidus dopamine and Parkinson motor subtypes: clinical and brain biochemical correlation

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5031365

Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5031365

Initiation and Synergistic Fibrillization of Tau and Alpha-Synuclein

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5031365

Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5031365

The association of incident dementia with mortality in PD.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5031365

A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5031365

The neuropathologic basis of different clinical subgroups of Parkinson's disease.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5031365

Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias

3 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00401-016-1552-2

10.1007/S00401-016-1552-2

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference

19 August 2017

1 reference